The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Offshoring in the Pharmaceutical Industry
Abstract
Offshoring has been adopted as a tool for reducing costs and for gaining strategic advantages by financial services, software development, and other competitive industries. For a variety of reasons, the pharmaceutical industry has been slow to take advantage of the benefits that offshoring can provide. The purpose of this article is to explore the internal and exogenous factors motivating global pharmaceutical firms to increase and expand their sourcing activities. And, instead of discussing global sourcing in general, India has been analyzed as a unique and explanatory case study for this new, emerging trend. The reasons behind this decision include India’s position as a renowned global IT hub, the country’s “home grown” biotechnology and biopharmaceutical industries, the numerous strategic partnerships and offshoring relationships between global and Indian firms, as well as its significant advances in IT and information management.
Related Content
|
Donald Carpenter, Vijay Agrawal.
© 2010.
18 pages.
|
|
Vanita Yadav, Rajen Gupta.
© 2010.
10 pages.
|
|
Luke Ho, Anthony Atkins.
© 2010.
21 pages.
|
|
Mahesh Raisinghani, Brandi Starr, Blake Hickerson, Marshelle Morrison, Michael Howard.
© 2010.
21 pages.
|
|
Robin Qiu.
© 2010.
18 pages.
|
|
Nicholas Beaumont.
© 2010.
21 pages.
|
|
Shirish Srivastava, Thompson Teo, Partha S. Mohapatra.
© 2010.
16 pages.
|
|
|